BTC $ 8,175.95 -1.77832%
ETH $ 180.02 -2.27699%
MARKET CAP $ 221 bln -1.54%
ICOs 5,502

Target Coin

Trading
11,740 Views
Target Coin is a tokenised long-short Cryptocurrency Fund which invests and trades in the CryptoCurrency market by utilizing machine learning and algorithmic trading strategies for optimum Alpha generation and risk adjusted returns.
General
Website: Visit
White paper: Read
ICO Time: 15 July 2017 - 31 Aug 2017
Country: India
Token info
Ticker: TGT
Platform: Ethereum
Available for sale: 1,340,000,000 TGT
Total supply: 2,000,100,000 TGT
Financial
Raised $ 20,711,412
ICO Price: ≈ 0.05 USD
Accepting: ETH
Screenshots taken 5 Feb 2018
Akshath Naik
CEO & Chairman
Rohan Rathod
Chief Technology Officer
Shaun Dsouza
Head of Sales & Trading
Prakhar Ahlawat
Chief Operating Officer
Rohit Ghaisas
Chief Legal Consultant

Advisors (0)

ICO Stats
Interesting ICOs
Active
TROY
TROY is the Ethereum-based cryptocurrency which is designed to allow both experienced and layman users to purchase gold products. The tokens issued during the Initial Token Offering will be accessible via one of the most secured and reliable digital asset wallet in the world. With the advancement of fingerprint, live facial and live retina technology, TROY is creating the world’s most secure and simultaneously user-friendly digital storage.
Upcoming
Bithemoth
Here at Bithemoth, we strive for excellence and the development of the blockchain world. Through a vigorous and highly intensive process, we selected strong and innovative leaders to become apart of the Bithemoth family and project. Our team stretches across the globe and with a diversity of strengths we will be able to make a huge impact in the blockchain world. Our ecosystem will include: 1. A Decentralized Digital Asset Exchange
 2. Enhanced and Revolutionary Security and Features
 3. A complete Marketplace and Trading Platform
 4. Fully supported ICO incubator
 5. Dedicated Support Systems and Infrastructure
 6. The Development of Brick and Mortar Locations

Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.
Active
Travelvee
Travelvee - oriented directly to the market for unoccupied rooms - which will be sold on exclusive terms, which are discussed between the hotel and the buyer - confidentially, of course with the help of Travelvee platform. Travelvee is a decentralized community of people who choose the best among exclusive offers for the purchase of hotel and tourist services of all levels, made only by them at their request from participants of the Travelvee platform: hotels, resorts, villas, chalets, apartments, cottages, gimping, houses for holidays, motels, hostels. The unique economics of the TRAVEL token is designed for super profits for token holders. The estimated growth of the TRAVEL token during the first 2 years will be at least 10 000%. How this result will be achieved is described in detail in the Whitepaper and the TRAVEL Token section.
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.